+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Self-assessment Q&A in Clinical Laboratory Science, III

  • Book

  • August 2020
  • Elsevier Science and Technology
  • ID: 4991155

Self-assessment Q&A in Clinical Laboratory Science, III, adds a variety of subject matter that addresses new concepts and emerging technology, particularly in the areas of kidney biomarkers, cancer biomarkers, molecular diagnostics, multiple myeloma, pharmacogenomics, novel cardiovascular biomarkers and biomarkers of neurologic diseases. The field of Clinical Laboratory Science continues to evolve and editor Alan Wu has once again brought together experts in the field to cover the contemporary topics that are being tested today. This updated bank of questions and answers is a must-have to sharpen knowledge and skills.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. Mass spectrometry 2. Kidney markers 3. Cancer markers 4. Pregnancy 5. Heavy metals and ICP-MS 6. Protein electrophoresis 7. Sepsis 8. Molecular diagnostics for infectious diseases 9. Clinical and forensic toxicology 10. Point-of-care testing 11. Point-of-care technology 12. Cardiac markers 13. Multiple myeloma 14. Liquid biopsy 15. Pharmacogenomics 16. Pharmacokinetics and pharmacodynamics 17. Reference ranges 18. Regulations 19. Hemolysis 20. Icterus 21. Lipemia 22. Pre-analytical variables 23. Bioinformatics 24. Therapeutic drug monitoring 25. Lab automation 26. Transplant TDM 27. Newborn screening 28. Lab statistics 29. Pediatric clinical chemistry 30. Hematology 31. Immunology 32. Autoimmune 33. Novel cardiovascular biomarkers 34. Antimicrobial�resistance testing 35. Biomarkers of neurologic diseases 36. HLA testing

Authors

Alan H.B. Wu Professor of Laboratory Medicine, School of Medicine, San Francisco, CA, USA. Dr. Alan Wu is a Professor of Laboratory Medicine at the University of California at San Francisco. He is the Co-Director of the Core Laboratory at the Zuckerberg San Francisco General Hospital. His research is focused on biomarkers of cardiovascular disease, clinical toxicology, and pharmacogenomics. In this capacity, his clinical and research laboratory conducts testing for routine analytes in blood, urine and cerebral spinal fluid for electrolytes, metabolites, hormones, proteins, and biomarkers. His particular area of interest is in cardiac biomarkers for acute cardiac diseases. He received a B.S. in both Chemistry and Biology at Purdue University and a Ph.D. in Analytical Chemistry at the University of Illinois. He was a professor at the University of Texas and the University of Connecticut prior to his current position at UCSF.